AtriCure
ATRC
ATRC
190 hedge funds and large institutions have $2.92B invested in AtriCure in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 52 increasing their positions, 75 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 37
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
31% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 75
Holders
190
Holding in Top 10
4
Calls
$5.03M
Puts
$466K
Top Buyers
| 1 | +$156M | |
| 2 | +$62.6M | |
| 3 | +$41.8M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$21.8M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$20.4M |
Top Sellers
| 1 | -$68.4M | |
| 2 | -$46.3M | |
| 3 | -$24.9M | |
| 4 |
Goldman Sachs
New York
|
-$24M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$12.3M |